SoaS score
6.9/10
Priced for it
The story
Dossier filings and BE clears feed the out-licensing pipeline; registrations are moving and the last call held steady, but the price already banks 33.5% growth.
SoaS score
6.9/10
Priced for it
Kwality Pharmaceuticals makes complex generic injectables and oral solids, mainly out-licensed and exported to 70+ countries.
The story
Dossier filings and BE clears feed the out-licensing pipeline; registrations are moving and the last call held steady, but the price already banks 33.5% growth.
The good
The bad
Growth Score
Strong
Revenue growth · 2Y view
Bear
22-25%
Base
32-35%
Bull
>35%
25 more live · 1 revised down